Martina Lichtenfels (BRA
Bachelor of Biological Sciences (PUCRS). PhD in Medical Sciences from UFRGS with a sandwich period at the German Research Cancer Center (DKFZ, Heidelberg). Postdoc in Pharmaceutical Biotechnology at Ludwig-Maximillians University (LMU, Munich). Researcher at Ziel Biosciences, and collaborating researcher at the Breast Group at Hospital São Lucas at PUCRS.
What happens in residual disease after neoadjuvant chemotherapy? Efficacy of a novel in vitro breast cancer chemoresistance platform to demonstrate high resistance to drugs
Drug resistance in luminal breast tumors: results of a novel in vitro breast cancer chemoresistance platform
Martina Lichtenfels (BRA)